Brian M. Culley

2017 - Mast Therapeutics

In 2017, Brian M. Culley earned a total compensation of $1.6M as Former Chief Executive Officer at Mast Therapeutics, a 97% increase compared to previous year.

Compensation breakdown

Bonus$53,575
Salary$128,580
Stock Awards$350,493
Other$1,049,589
Total$1,582,237

Culley received $1M in other compensation, accounting for 66% of the total pay in 2017.

Culley also received $53.6K in bonus, $128.6K in salary and $350.5K in stock awards.

Rankings

In 2017, Brian M. Culley's compensation ranked 6,691st out of 14,666 executives tracked by ExecPay. In other words, Culley earned more than 54.4% of executives.

ClassificationRankingPercentile
All
6,691
out of 14,666
54th
Division
Manufacturing
2,475
out of 5,768
57th
Major group
Chemicals And Allied Products
799
out of 2,074
62nd
Industry group
Drugs
617
out of 1,730
64th
Industry
Pharmaceutical Preparations
486
out of 1,329
63rd
Source: SEC filing on April 23, 2018.

Culley's colleagues

We found six more compensation records of executives who worked with Brian M. Culley at Mast Therapeutics in 2017.

2017

Edwin Parsley

Mast Therapeutics

Former Chief Medical Office & Senior Vice President

2017

Brandi Roberts

Mast Therapeutics

Chief Financial Officer

2017

Robert Neville

Mast Therapeutics

Chief Executive Officer

2017

Taneli Jouhikainen

Mast Therapeutics

Chief Operating Officer

2017

Shana Hood

Mast Therapeutics

General Counsel

2017

Dave Lowrance

Mast Therapeutics

Chief Financial Officer

News

You may also like